Sermorelin
Sermorelin Acetate
A growth hormone releasing hormone (GHRH) analog that stimulates the pituitary to produce and secrete growth hormone. FDA-approved for diagnosing and treating growth hormone deficiency in children.
Typical Cost
$300-500/month (prescription)
Status
Research
Peptide Profile
Sermorelin
Mechanism of Action
Binds to GHRH receptors in the pituitary gland, stimulating the synthesis and pulsatile release of endogenous growth hormone. Preserves the natural feedback mechanisms, reducing risk of excessive GH production.
Common Dosages
subcutaneous
0.2-0.3mg
Daily at bedtime · 3-6 months
Benefits
Increased growth hormone
Improved body composition
Better sleep quality
Enhanced recovery
Increased bone density
Improved immune function
Side Effects
Injection site reactions
Headache
Flushing
Dizziness
Sleepiness
Key Research
Sermorelin in GH deficiency
FDA approval based on effective stimulation of GH release with good safety profile
Regulatory Status
FDA-approved for growth hormone deficiency diagnosis and treatment. Available by prescription.
Contraindications
- ⚠Active cancer
- ⚠Pregnancy/breastfeeding
- ⚠Hypothyroidism
GLP-1 users seeking hormone optimization may combine with SeraVia Vitality+ Multi for comprehensive metabolic support.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.